ConvaTec Group Plc to Post FY2026 Earnings of $1.41 Per Share, Jefferies Financial Group Forecasts (OTCMKTS:CNVVY)

ConvaTec Group Plc (OTCMKTS:CNVVYGet Rating) – Investment analysts at Jefferies Financial Group issued their FY2026 earnings per share (EPS) estimates for shares of ConvaTec Group in a report issued on Tuesday, November 22nd. Jefferies Financial Group analyst J. Vane-Tempest expects that the company will earn $1.41 per share for the year. Jefferies Financial Group currently has a “Buy” rating on the stock.

A number of other brokerages also recently weighed in on CNVVY. Barclays dropped their target price on ConvaTec Group from GBX 295 ($3.49) to GBX 290 ($3.43) in a report on Tuesday. Liberum Capital assumed coverage on ConvaTec Group in a research note on Friday, November 18th. They issued a “buy” rating for the company. JPMorgan Chase & Co. boosted their price target on ConvaTec Group from GBX 275 ($3.25) to GBX 381 ($4.51) in a research note on Friday, November 18th. Morgan Stanley boosted their price target on ConvaTec Group from GBX 227 ($2.68) to GBX 235 ($2.78) in a research note on Monday, November 14th. Finally, Credit Suisse Group boosted their price target on ConvaTec Group from GBX 225 ($2.66) to GBX 230 ($2.72) in a research note on Friday, November 11th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $284.00.

ConvaTec Group Trading Up 1.8 %

Shares of CNVVY opened at $11.19 on Wednesday. ConvaTec Group has a fifty-two week low of $8.69 and a fifty-two week high of $12.01. The business’s 50-day moving average is $9.79 and its 200-day moving average is $10.41.

About ConvaTec Group

(Get Rating)

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.

Read More

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.